#1 Clinical Trials Search in Europe

Beclometasone Dipropionate

This article examines the use of Beclomethasone Dipropionate (BDP) in clinical trials for treating asthma and other respiratory conditions. BDP is an inhaled corticosteroid medication that helps reduce inflammation in the airways. We’ll look at studies testing different formulations, dosages, and applications of BDP to better understand its efficacy and safety profile in both adults and children with respiratory issues.

Table of Contents

What is Beclomethasone Dipropionate?

Beclomethasone Dipropionate is a medication that belongs to a class of drugs called corticosteroids. It is commonly used to treat various respiratory conditions, particularly asthma[1]. This medication is also known by several other names, including:

  • BDP
  • QVAR®
  • Beclomethasone 17,21-dipropionate
These alternative names may appear on your prescription or medication packaging[2][1].

Uses and Conditions Treated

Beclomethasone Dipropionate is primarily used to treat:

  • Asthma: It is commonly prescribed for both adults and children with asthma, particularly those with mild persistent asthma[1].
  • Bronchopulmonary Dysplasia: This is a condition that affects premature infants and can cause breathing difficulties[3].
  • Ulcerative Proctosigmoiditis: In some cases, it may be used to treat this inflammatory bowel condition[2].
The medication helps to control symptoms and prevent asthma attacks, allowing patients to lead normal, active lives[1].

How It Works

Beclomethasone Dipropionate works by reducing inflammation in the airways. When you inhale the medication, it coats the inside of your airways and helps to:

  • Decrease swelling and irritation
  • Reduce mucus production
  • Relax the muscles around the airways
These effects make it easier to breathe and help prevent asthma symptoms from occurring[4].

Administration Methods

Beclomethasone Dipropionate can be administered in several ways:

  • Metered Dose Inhaler (MDI): A handheld device that delivers a precise amount of medication when you press down on the canister[5].
  • Breath-Actuated Inhaler (BAI): Similar to an MDI, but it releases the medication when you inhale, making it easier to use[5].
  • Dry Powder Inhaler (DPI): A device that delivers the medication in a dry powder form when you inhale deeply[4].
  • Suppositories: In some cases, the medication may be administered rectally for conditions like ulcerative proctosigmoiditis[2].
Your doctor will prescribe the most appropriate method based on your condition and personal needs.

Dosage and Frequency

The dosage and frequency of Beclomethasone Dipropionate can vary depending on several factors, including:

  • The severity of your condition
  • Your age
  • The specific formulation being used
For asthma treatment, common dosages include:
  • 40 mcg to 80 mcg per puff, taken twice daily[1]
  • 100 mcg to 200 mcg per puff, taken twice daily[6]
It’s crucial to follow your doctor’s instructions precisely and not to adjust your dosage without consulting them first.

Effectiveness and Benefits

Beclomethasone Dipropionate has been shown to be effective in:

  • Improving lung function[4]
  • Reducing the frequency and severity of asthma symptoms[1]
  • Decreasing the need for rescue medications[1]
  • Improving quality of life for asthma patients[1]
Regular use of this medication as prescribed can help you maintain better control over your asthma and reduce the risk of severe asthma attacks.

Safety and Side Effects

Beclomethasone Dipropionate is generally considered safe when used as directed. However, like all medications, it can cause side effects. Some potential side effects include:

  • Throat irritation or hoarseness
  • Oral thrush (a fungal infection in the mouth)
  • Coughing
In rare cases, inhaled corticosteroids may affect growth in children or impact the body’s ability to produce natural steroids. Your doctor will monitor for these effects during treatment[7].

Ongoing Research

Researchers continue to study Beclomethasone Dipropionate to improve its effectiveness and understand its long-term effects. Current areas of research include:

  • Comparing different dosing regimens to find the most effective approach[6]
  • Investigating its use in treating bronchopulmonary dysplasia in premature infants[3]
  • Studying the effects of combining Beclomethasone Dipropionate with other medications[4]
These ongoing studies aim to improve treatment options and outcomes for patients with respiratory conditions.

Aspect Details
Drug Name Beclomethasone Dipropionate (BDP)
Drug Type Inhaled corticosteroid
Primary Use Treatment of asthma and other respiratory conditions
Delivery Methods Metered-dose inhalers (MDIs), breath-actuated inhalers (BAIs), nebulizers
Dosage Forms Various strengths (e.g., 40 mcg, 80 mcg, 100 mcg per actuation)
Treatment Regimens Daily maintenance, rescue medication, or combination of both
Patient Populations Adults and children with asthma or recurrent wheezing
Key Outcome Measures Lung function, asthma exacerbations, quality of life, asthma control
Safety Considerations Effects on HPA axis, growth in children, local side effects

FAQ

  • What is Beclomethasone Dipropionate and how does it work? Beclomethasone Dipropionate (BDP) is an inhaled corticosteroid medication used to treat asthma and other respiratory conditions. It works by reducing inflammation in the airways, which helps to improve breathing and prevent asthma symptoms and exacerbations.
  • What types of inhalers are used to deliver Beclomethasone Dipropionate? BDP can be delivered through different types of inhalers, including metered-dose inhalers (MDIs), breath-actuated inhalers (BAIs), and nebulizers. Some studies compare the effectiveness of these different delivery methods.
  • Is Beclomethasone Dipropionate used for both daily maintenance and rescue treatment of asthma? Yes, some clinical trials are exploring the use of BDP for both daily maintenance therapy and as a rescue medication. For example, one study compares using BDP twice daily for maintenance plus as-needed for rescue, versus using it only as a rescue medication.
  • Are there any studies on using Beclomethasone Dipropionate in children? Yes, several clinical trials are investigating the use of BDP in children with asthma or recurrent wheezing. These studies aim to determine the appropriate dosages and assess the safety and efficacy of BDP in pediatric populations.
  • What are some of the outcomes measured in Beclomethasone Dipropionate clinical trials? Clinical trials typically measure outcomes such as lung function (e.g., FEV1, peak expiratory flow rate), frequency of asthma exacerbations, quality of life, asthma control days, and safety parameters. Some studies also look at the medication's effects on the body's stress response system.

Ongoing Clinical Trials on Beclometasone Dipropionate

  • Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

    Recruiting

    1 1 1
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Latvia Poland +2

  • Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Germany Italy Poland Romania +2

  • Study of inhaled corticosteroids (beclometasone, fluticasone, budesonide) and salbutamol in children aged 1-6 years with episodic wheezing

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effectiveness of Beclometasone, Glycopyrronium, and Formoterol in COPD Patients with Asthma Characteristics

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Beclomethasone Dipropionate (BDP): An inhaled corticosteroid medication used to treat asthma and other respiratory conditions by reducing inflammation in the airways.
  • Metered-Dose Inhaler (MDI): A device that delivers a specific amount of medication to the lungs in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation.
  • Breath-Actuated Inhaler (BAI): An inhaler that releases medication when the patient inhales, making it easier to coordinate breathing and medication release.
  • Nebulizer: A device that changes liquid medicine into a fine mist, allowing easier inhalation of the medication into the lungs.
  • Forced Expiratory Volume in One Second (FEV1): The amount of air a person can forcefully exhale in one second, used as a measure of lung function.
  • Peak Expiratory Flow Rate (PEFR): The maximum rate of airflow achieved during a forceful exhalation, used to measure lung function and airway obstruction.
  • Asthma Exacerbation: A worsening of asthma symptoms that may require additional medication or medical intervention.
  • Hydrofluoroalkane (HFA): A propellant used in metered-dose inhalers to deliver medication to the lungs.
  • Bronchopulmonary Dysplasia (BPD): A chronic lung disease that affects premature infants, characterized by inflammation and scarring in the lungs.
  • Hypothalamic-Pituitary-Adrenal (HPA) Axis: A complex set of interactions among three endocrine glands that control reactions to stress and regulate various body processes.
  • Airway Resistance: The opposition to airflow in the respiratory tract, which can be increased in conditions like asthma.

References

  1. https://clinicaltrials.gov/study/NCT00394329
  2. https://clinicaltrials.gov/study/NCT04873063
  3. https://clinicaltrials.gov/study/NCT03503994
  4. https://clinicaltrials.gov/study/NCT01650441
  5. https://clinicaltrials.gov/study/NCT02030457
  6. https://clinicaltrials.gov/study/NCT05292586
  7. https://clinicaltrials.gov/study/NCT01658891